BTIG Upgrades Staar Surgical to Buy, Announces $46 Price Target
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Ryan Zimmerman has upgraded Staar Surgical (NASDAQ:STAA) from Neutral to Buy and set a price target of $46.
June 11, 2024 | 5:38 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BTIG analyst Ryan Zimmerman has upgraded Staar Surgical from Neutral to Buy and set a price target of $46.
The upgrade from Neutral to Buy and the announcement of a $46 price target by a reputable analyst is likely to positively impact investor sentiment and drive short-term price appreciation for Staar Surgical.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100